Eli Lilly Corp. buy UBS Group AG
Start price
24.05.23
/
50%
€397.00
Target price
24.05.24
€462.89
Performance (%)
88.34%
End price
25.05.24
€747.70
Summary
This prediction ended on 25.05.24 with a price of €747.70. With a performance of 88.34% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. A total of €4.48 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 5.401% | 5.401% | 20.146% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at UBS Group AG from $447.00 to $498.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€537.70
08.08.25
08.08.25
€767.46
08.08.26
08.08.26
68.03%
15.12.25
15.12.25
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€781.50
07.11.25
07.11.25
€936.04
07.11.26
07.11.26
15.61%
15.12.25
15.12.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€557.00
20.10.23
20.10.23
€670.67
20.10.24
20.10.24
51.40%
21.10.24
21.10.24